Comparison of Cervical Cancer Screening Results Among 256,648 Women in Multiple Clinical Practices

BACKGROUND: In the United States, human papillomavirus (HPV) and Papanicolaou (Pap) testing (cotesting) for cervical screening in women ages 30 to 65 years is the preferred strategy, and cytology alone is acceptable. Recently, a proprietary automated test for identifying high-risk HPV types for prim...

Descripción completa

Detalles Bibliográficos
Autores principales: Blatt, Amy J, Kennedy, Ronald, Luff, Ronald D, Austin, R Marshall, Rabin, Douglas S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654274/
https://www.ncbi.nlm.nih.gov/pubmed/25864682
http://dx.doi.org/10.1002/cncy.21544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654274/
https://www.ncbi.nlm.nih.gov/pubmed/25864682
http://dx.doi.org/10.1002/cncy.21544

Ejemplares similares